A Polygenic Model of the Metabolic Syndrome With Reduced Circulating and Intra-Adipose Glucocorticoid Action
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Despite major advances in understanding monogenic causes of morbid obesity, the complex genetic and environmental etiology of idiopathic metabolic syndrome remains poorly understood. One hypothesis suggests that similarities between the metabolic disease of plasma glucocorticoid excess (Cushing’s syndrome) and idiopathic metabolic syndrome results from increased glucocorticoid reamplification within adipose tissue by 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD-1). Indeed, 11β-HSD-1 is now a major therapeutic target. Because much supporting evidence for a role of adipose 11β-HSD-1 comes from transgenic or obese rodents with single-gene mutations, we investigated whether the predicted traits of metabolic syndrome and glucocorticoid metabolism were coassociated in a unique polygenic model of obesity developed by long-term selection for divergent fat mass (Fat and Lean mice with 23 vs. 4% fat as body weight, respectively). Fat mice exhibited an insulin-resistant metabolic syndrome including fatty liver and hypertension. Unexpectedly, Fat mice had a marked intra-adipose (11β-HSD-1) and plasma glucocorticoid deficiency but higher liver glucocorticoid action. Furthermore, metabolic disease was exacerbated only in Fat mice when challenged with exogenous glucocorticoids or a high-fat diet. Our data suggest that idiopathic metabolic syndrome might associate with such a novel pattern of glucocorticoid action and sensitivity in humans, with implications for tissue-specific therapeutic targeting of 11β-HSD-1.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A transgenic model of visceral obesity and the metabolic syndrome
Masuzaki, H., Paterson, J., Shinyama, H., Morton, N. M., Mullins, J. J., Seckl, J. R., & Flier, J. S. (2001) · Science · doi:10.1126/science.1066285 · Cited by 1,766 · cited 10×
“Although it is abundantly clear that aberrantly elevated adipose 11 -HSD-1 can drive a complete metabolic syndrome in mice (7,17) and potentially contributes to it in humans (13–15), there is a precedent for obesity with low FIG.”
BackgroundResultInfluentialSelf-citationMorton, N. M., Paterson, J. M., Masuzaki, H., Holmes, M. C., Staels, B., Fievet, C., Walker, B. R., Flier, J. S., Mullins, J. J., & Seckl, J. R. (2004) · Diabetes · doi:10.2337/diabetes.53.4.931 · Cited by 512 · cited 10×
“Weight gain in Fat mice on the high-fat diet was associated with a 34% (body weight adjusted) increase in subcutaneous fat mass but a 25% reduction in mesenteric adipose fat mass with high-fat feeding (Table 4), a pattern of preferential fat deposition similar to 11 -HSD-1–deficient mice (20).”
BackgroundMethodInfluentialSelf-citationMasuzaki, H., Yamamoto, H., Kenyon, C. J., Elmquist, J. K., Morton, N. M., Paterson, J. M., Shinyama, H., Sharp, M. G. F., Fleming, S., Mullins, J. J., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17845 · Cited by 434 · cited 4×
“Although it is abundantly clear that aberrantly elevated adipose 11 -HSD-1 can drive a complete metabolic syndrome in mice (7,17) and potentially contributes to it in humans (13–15), there is a precedent for obesity with low FIG.”
BackgroundMethodInfluentialSelf-citationMcLaughlin, T., Allison, G., Abbasi, F., Lamendola, C., & Reaven, G. (2004) · Metabolism · doi:10.1016/j.metabol.2003.10.032 · Cited by 268 · cited 1×
“Furthermore, although obesity often associates with insulin resistance and metabolic disease (33), this relationship is not inevitable (34,35).”
BackgroundDIMITRIADIS, G., LEIGHTON, B., PARRY-BILLINGS, M., SASSON, S., YOUNG, M., KRAUSE, U., BEVAN, S., PIVA, T., WEGENER, G., & NEWSHOLME, E. A. (1997) · Biochemical Journal · doi:10.1042/bj3210707 · Cited by 266
Lindsay, R. S., Wake, D. J., Nair, S., Bunt, J., Livingstone, D. E. W., Permana, P. A., Tataranni, P. A., & Walker, B. R. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-030017 · Cited by 225 · cited 1×
“This view is supported by recent human studies showing that adipose 11 -HSD-1 correlates more strongly with insulin resistance than with adiposity per se (15,41).”
ResultInbred lines of mice derived from long-term divergent selection on fat content and body weight
Bünger, L., & Hill, W. G. (1999) · Mammalian Genome · doi:10.1007/s003359901063 · Cited by 45
Self-citation
Cited by
Mechanisms of Glucocorticoid-Induced Insulin Resistance
Geer, E. B., Islam, J., & Buettner, C. (2014) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2013.10.005 · Cited by 392
Cooper, M. S., & Stewart, P. M. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1412 · Cited by 183
Identification of ALK in thinness
Orthofer, M., Valsesia, A., Mägi, R., Wang, Q.-P., Kaczanowska, J., Kozieradzki, I., Leopoldi, A., Cikes, D., Zopf, L. M., Tretiakov, E. O., et al. (2020) · Cell · doi:10.1016/j.cell.2020.04.034 · Cited by 117
Witchel, S. F., & DeFranco, D. B. (2006) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0323 · Cited by 58
Metadata
- Authors
- Morton, N. M., Densmore, V., Wamil, M., Ramage, L., Nichol, K., Bünger, L., Seckl, J. R., & Kenyon, C. J.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2005-12-01
- Volume
- 54
- Issue
- 12
- Pages
- 3371-3378
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2159578036
- Cited by
- 66
- References
- 7
- FWCI
- 3.49
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A Polygenic Model of the Metabolic Syndrome With Reduced Circulating and Intra-Adipose Glucocorticoid Action. https://app.cochat.ai/papers/10.2337/diabetes.54.12.3371
- The paper
- Morton, N. M., Densmore, V., Wamil, M., Ramage, L., Nichol, K., Bünger, L., Seckl, J. R., & Kenyon, C. J. (2005). A Polygenic Model of the Metabolic Syndrome With Reduced Circulating and Intra-Adipose Glucocorticoid Action. Diabetes. https://doi.org/10.2337/diabetes.54.12.3371
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.